Abbrea Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$481K Hold
6,848
0.06% 158
2024
Q1
$508K Buy
6,848
+215
+3% +$15K 0.07% 160
2023
Q4
$439K Sell
6,633
-150
-2% -$9.39K 0.06% 166
2023
Q3
$427K Sell
6,783
-130
-2% -$8.1K 0.07% 167
2023
Q2
$391K Buy
6,913
+240
+4% +$13.3K 0.06% 175
2023
Q1
$387K Buy
6,673
+290
+5% +$19.6K 0.07% 174
2022
Q4
$462K Buy
6,383
+870
+16% +$62.3K 0.08% 156
2022
Q3
$335K Sell
5,513
-54
-1% -$3.45K 0.06% 166
2022
Q2
$350K Buy
5,567
+525
+10% +$34.8K 0.06% 171
2022
Q1
$354K Buy
5,042
+150
+3% +$10.1K 0.05% 194
2021
Q4
$306K Sell
4,892
-220
-4% -$13.8K 0.04% 208
2021
Q3
$316K Buy
5,112
+1,233
+32% +$74.2K 0.05% 200
2021
Q2
$232K Buy
3,879
+465
+14% +$29.5K 0.03% 223
2021
Q1
$208K Buy
+3,414
New +$188K 0.03% 219
2020
Q1
Sell
-5,255
Closed -$268K 186
2019
Q4
$268K Sell
5,255
-200
-4% -$9.65K 0.06% 172
2019
Q3
$257K Buy
5,455
+615
+13% +$29.3K 0.06% 166
2019
Q2
$240K Buy
+4,840
New +$227K 0.06% 171

Other funds holding MET

Abbrea Capital's MET Position: Q2 2024 in Review

Abbrea Capital held its MetLife (MET) position steady in Q2 2024 at 6,848 shares worth $481K. The position accounts for 0.06% of the portfolio, ranked #158.

Abbrea Capital first reported a position in MET in Q2 2019 and has held it in 17 quarters since. The position peaked at $508K in Q1 2024. 1,298 funds tracked by Wall St. Rank hold MET as of Q2 2024.

  • Abbrea Capital held 6,848 shares of MetLife worth $481K as of Q2 2024.
  • Abbrea Capital left its MetLife share count unchanged in Q2 2024.
  • MetLife made up 0.06% of Abbrea Capital's portfolio in Q2 2024, its #158 holding.
  • Abbrea Capital first reported a position in MetLife in Q2 2019 and has held it in 17 quarters since.
  • Abbrea Capital's MetLife position peaked at $508K in Q1 2024.
  • 1,298 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.